No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Immunome, Inc.'s (NASDAQ:IMNM) Institutional Investors Lost 6.0% Last Week but Have Benefitted From Longer-term Gains
Immunome Insiders Added US$2.67m Of Stock To Their Holdings
STALICLA Appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors
Express News | Immunome Appoints Phil Tsai as Chief Technical Officer
Evaluating Immunome: Insights From 4 Financial Analysts
Immunome Initiated at Overweight by Piper Sandler